Omicron-adapted vaccines will be delivered to the European Union within days of regulatory approval, European member of parliament Peter Liese said on Wednesday.

The European Medicines Agency (EMA) is expected to make a decision this week on Moderna and Pfizer-BioNTech vaccines tailored to target the older BA.1 Omicron variant as well as the original strain that first emerged in China.

UK TO OFFER ALL ADULTS COVID BOOSTER BEGINNING IN SEPTEMBER

Moderna will provide the EU with 70 million vaccine doses in the first two months, with eight to 11 million expected to be available as early as the first week of September, and Germany is scheduled to receive four million doses in the first two weeks after approval, Liese said in a statement.

Crowded subway

Commuters mask up on a crowded subway car durring the height of the omicron outbreak in Barcelona, Spain, on Jan. 12, 2022. Europe is set to recieve the new omicron resistant COVID booster within days of approval. (REUTERS/Nacho Doce/Files)

Meanwhile, up to 29 million doses of the vaccine made by Pfizer and BioNTech are expected to be delivered in September to Germany alone, including 10 million in the first two weeks after approval, he added.

"We cannot comment on future deliveries," a European Commission spokesman said.

AS THE BA.5 OMICRON SUBVARIANT SURGES, VACCINE EXPERTS URGE HIGH RISK PEOPLE TO GET COVID-19 BOOSTER NOW

Representatives of Moderna, Pfizer and BioNTech were not immediately available for comment.